Advertisement
- South Korea
- /
- Medical Equipment
- /
- KOSDAQ:A253840
Sugentech Full Year 2024 Earnings: ₩994 loss per share (vs ₩1,090 loss in FY 2023)
Sugentech (KOSDAQ:253840) Full Year 2024 Results
Key Financial Results
- Revenue: ₩10.1b (up 42% from FY 2023).
- Net loss: ₩15.2b (loss narrowed by 12% from FY 2023).
- ₩994 loss per share (improved from ₩1,090 loss in FY 2023).
All figures shown in the chart above are for the trailing 12 month (TTM) period
Sugentech shares are down 4.3% from a week ago.
Risk Analysis
Before we wrap up, we've discovered 2 warning signs for Sugentech (1 makes us a bit uncomfortable!) that you should be aware of.
New: Manage All Your Stock Portfolios in One Place
We've created the ultimate portfolio companion for stock investors, and it's free.
• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About KOSDAQ:A253840
Sugentech
Develops and sells in-vitro diagnostic systems and products based on biotechnology, information technology, and nanotechnology in South Korea and internationally.
Excellent balance sheet with very low risk.
Market Insights
Advertisement
Weekly Picks
DA
davidlsander on Ubisoft Entertainment ·
Is Ubisoft the Market’s Biggest Pricing Error? Why Forensic Value Points to €33 Per Share
Fair Value:€33.888.0% undervalued
39 followersusers have followed this narrative
3 commentsusers have commented on this narrative
19 likesusers have liked this narrative
TO
Tokyo on LVMH Moët Hennessy - Louis Vuitton Société Européenne ·
EU#4 - Turning Heritage into the World’s Strongest Luxury Empire
Fair Value:€750.0428.2% undervalued
4 followersusers have followed this narrative
0 commentsusers have commented on this narrative
9 likesusers have liked this narrative
WE
WealthAP on Alphabet ·
The "Easy Money" Is Gone: Why Alphabet Is Now a "Show Me" Story
Fair Value:US$386.4314.3% undervalued
62 followersusers have followed this narrative
1 commentusers have commented on this narrative
19 likesusers have liked this narrative
Recently Updated Narratives
HE
HegelBayeBagel on PlaySide Studios ·
PlaySide Studios: Market Is Sleeping on a Potential 10M+ Unit Breakout Year, FY26 Could Be the Rerate of the Decade
Fair Value:AU$0.8467.9% undervalued
1 followerusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
andre_santos on Amazon.com ·
Amazon - A Fundamental and Historical Valuation
Fair Value:US$168.1232.5% overvalued
22 followersusers have followed this narrative
2 commentsusers have commented on this narrative
0 likesusers have liked this narrative
RE
RecMag on Proximus ·
Proximus: The State-Backed Backup Plan with 7% Gross Yield and 15% Currency Upside.
Fair Value:€17.1353.8% undervalued
38 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Popular Narratives
OO
OOO97 on Neo Performance Materials ·
Undervalued Key Player in Magnets/Rare Earth
Fair Value:CA$25.3325.7% undervalued
75 followersusers have followed this narrative
0 commentsusers have commented on this narrative
19 likesusers have liked this narrative
WE
WealthAP on PayPal Holdings ·
The "Sleeping Giant" Stumbles, Then Wakes Up
Fair Value:US$8251.3% undervalued
88 followersusers have followed this narrative
6 commentsusers have commented on this narrative
35 likesusers have liked this narrative
DA
davidlsander on Ubisoft Entertainment ·
Is Ubisoft the Market’s Biggest Pricing Error? Why Forensic Value Points to €33 Per Share
Fair Value:€33.888.0% undervalued
39 followersusers have followed this narrative
3 commentsusers have commented on this narrative
19 likesusers have liked this narrative
Trending Discussion
KA
Kalibrator on Ubisoft Entertainment ·
As a gamer, I would not touch this company now. They are hated by the community and have been releasing major flops on their AAA games during the last 5 years (for good reasons). It is true that the valuation is ridiculously low compared to what the licenses are worth, but if the trend continues the value of those will also decline. Management needs to almost make a 180° turnaround to get things right. I agree that a take-private deal before it is too late might be the best option for an investor entering today. We might also see a split sales of the different studios. It is a very risky play, but potentially with high reward.
1
|0
